Countries citing papers authored by Ross Pinkerton
Since
Specialization
Citations
This map shows the geographic impact of Ross Pinkerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Pinkerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Pinkerton more than expected).
This network shows the impact of papers produced by Ross Pinkerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Pinkerton. The network helps show where Ross Pinkerton may publish in the future.
Co-authorship network of co-authors of Ross Pinkerton
This figure shows the co-authorship network connecting the top 25 collaborators of Ross Pinkerton.
A scholar is included among the top collaborators of Ross Pinkerton based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ross Pinkerton. Ross Pinkerton is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lobb, Michael, et al.. (2011). Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients. Therapeutic Drug Monitoring. 33(4). 547–547.1 indexed citations
8.
Gerrard, Mary, Richard Sposto, A. Aupérin, et al.. (2005). Deletion of cranial irradiation and addition of systemic high dose methotrexate and intrathecal chemotherapy results in 70% 4-yr. EFS in children and adolescents with CNS positive B-NHL: Results of International FAB/LMB 96 study. Annals of Oncology. 16. 62–62.6 indexed citations
9.
Gerrard, Mary, Richard Sposto, A. Aupérin, et al.. (2003). Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96.. Blood. 102(11).1 indexed citations
Kościelniak, Ewa, Giovanni Rosti, Oliver Hartmann, et al.. (1999). 20 yrs experience with high dose chemotherapy (HDC) in patients with metastatic and recurrent rhabdomyosarcoma (RMS). An EBMT solid tumor working party update 1998.. Bone Marrow Transplantation. 23.1 indexed citations
12.
Gebhard, F., G Leverger, Ross Pinkerton, et al.. (1998). High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).. Blood. 92(10).9 indexed citations
13.
Koscielniak, E., Gianantonio Rosti, J. Treuner, et al.. (1998). Prognosis in patients with primary bone and/or bone marrow metastases(MET) of rhabdomyosarcoma (RMS). A joint report of the EBMT solid tumor working party and the German soft tissue sarcoma study (CWS).. Bone Marrow Transplantation. 21.
14.
Pinkerton, Ross. (1994). Chimiothérapie massive suivie d'autogreffe de moelle en encologie pédiatrique : les arguments contre. Bulletin du Cancer. 82(1). 42–45.1 indexed citations
Pinkerton, Ross. (1992). Megatherapy in childhood sarcoma. A decade of phase II studies : what next ?. Bone Marrow Transplantation. 10(2). 19–19.3 indexed citations
17.
Ladenstein, Ruth, Christine Lasset, Pierre Biron, et al.. (1992). The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registry. Bone Marrow Transplantation. 10(2). 20–20.3 indexed citations
18.
Lasset, Christine, Olivier Hartmann, Guglielmo Dini, et al.. (1992). The Lyon and the Ebmt Data On Megatherapy (Mgt) in Neuroblastoma Followed by Bone-Marrow Rescue. Bone Marrow Transplantation. 10(2). 14–14.2 indexed citations
19.
Dini, Giorgio, T Philip, Olivier Hartmann, et al.. (1989). Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group.. PubMed. 4 Suppl 4. 42–6.14 indexed citations
20.
Koscielniak, E., J. Treuner, Modesto Carli, et al.. (1988). Rapid High-Dose Intensity Chemotherapy Including High-Dose Melphalan (Hdm) for Rhabdomyosarcoma. Medical and Pediatric Oncology. 16(6). 430–430.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.